Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00701870 · ClinicalTrials.gov registry record · Phase 2
Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer
A Phase 2 study, sponsored by Telik.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00701870: Clinical Trial Phase 2 study, sponsored by Telik.
NCT00701870 is a Phase 2 study that was terminated before completion, run by Telik. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00701870, a Phase 2 study, was terminated before completion, sponsored by Telik.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
TLK199.2102 was a multicenter Phase 2 randomized study to determine the effect of Telintra treatment on chemotherapy induced neutropenia (CIN) in patients with non small cell lung cancer receiving first-line therapy with carboplatin and docetaxel.
Interventions
- DRUG ezatiostat hydrochloride (Telintra®)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-10 |
| Est. Completion | 2008-11 |
| Phase | Phase 2 |
Why NCT00701870 stopped before completion
NCT00701870 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which ezatiostat hydrochloride (Telintra®) is the first listed.
NCT00701870 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00701870 about?
NCT00701870 is a clinical study titled "Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer". TLK199.2102 was a multicenter Phase 2 randomized study to determine the effect of Telintra treatment on chemotherapy induced neutropenia (CIN) in patients with non small cell lung cancer receiving first-line therapy with carboplatin and docetaxel.
What is the current status of trial NCT00701870?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2008-10. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00701870?
The interventions under investigation include: ezatiostat hydrochloride (Telintra®) (DRUG).
Who is sponsoring clinical trial NCT00701870?
This trial is sponsored by Telik, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00701870's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia